ONDANSETRON VIATRIS 2 mg/ml, solution for injection (i.v.) ampoule, 2 ml
Active ingredients: Ondansetron, Ondansetron hydrochloride hydrate
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injectionampoule, 2 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ONDANSETRON VIATRIS 2 mg/ml, solution injectable (I.V.)
- Pharmaceutical form
- solution injectable
- Route of administration
- intraveineuse
- Presentation description
- 1 ampoule(s) en verre brun de 2 ml
- Marketing authorisation holder
- VIATRIS SANTE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 9 Oct 2015
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63988721CIP73766926CIP133400937669269Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ONDANSÉTRON (CHLORHYDRATE D') DIHYDRATÉsolution | — | SA |
| ONDANSÉTRONsolution | 2 mg · 1 ml de solution injectable | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.